semaglutide compound deaths Off-Label Linked to Deaths, Hospitalizations Calling for Compounding Regulation Semaglutide Patient Safety Updates |

[2] When to seek urgent advice: Contact your GP or healthcare provider promptly if you: Suspect you may be pregnant whilst taking GLP-1 medication Experience sudden changes in menstrual patterns Develop severe abdominal pain (especially if radiating to the back), persistent vomiting, or signs of gallbladder problems Experience severe, persistent vomiting or diarrhoea leading to dehydration Your healthcare team can coordinate care between endocrinology, gynaecology, and fertility services as needed, ensuring that your weight management and reproductive health goals are addressed safely and effectively

The realistic window

While Ozempic works on one receptor (GLP-1), and Mounjaro works on two (GLP-1 and GIP), retatrutide hits all three: GLP-1, GIP, and glucagon

Only 3.3% of patients on the higher dose stopped treatment because of GI-related side effects

Get in touch with us for a consultation today

References: -Frias JP, Hsia S, Eyde S, et al